__NUXT_JSONP__("/drugs/Mapatumumab", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:b,chebiId:b,chemicalFormula:b,definition:"A fully human agonistic monoclonal antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor-1 (TRAIL-R1) with apoptosis promoting and potential antitumor activities. TRAIL-R1 is a cell surface receptor expressed on many malignant cell types. Mapatumumab selectively binds to and activates the TRAIL cell receptor, thereby inducing apoptosis and reducing tumor growth.",fdaUniiCode:"WZ1025JPGR",identifier:"C61502",preferredName:a,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C20401"],synonyms:["Anti-TRAIL R1-mAb","HGS-ETR1","MAPATUMUMAB",a,"TRM-1 mAb","anti-TRAIL R1-mAb"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FMapatumumab",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Mapatumumab","","2021-10-30T13:41:33.023Z")));